openPR Logo
Press release

Infertility treatment market to grow from $2.9 Billion in 2024 to $6 Billion in 2033 at 8.1% CAGR, driven IVF adoption

09-01-2025 12:27 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Infertility treatment market

Infertility treatment market

According to DataM Intelligence, the infertility treatment market size was valued at USD 2,981.35 million in 2024 and is estimated to reach USD 6,009.58 million in 2033 at a compound annual growth rate (CAGR) of 8.10% over the forecast period 2025-2033. North America currently leads the global market, thanks to advanced healthcare infrastructure, high awareness levels, and supportive insurance policies for fertility treatments. However, the Asia-Pacific region is emerging as the fastest-growing market, fueled by rapid urbanization, rising infertility cases, and government-backed healthcare initiatives. Assisted reproductive technologies such as in-vitro fertilization (IVF) dominate the market due to their high success rates and widespread acceptance among couples.

The global infertility treatment market is witnessing steady growth, driven by rising infertility rates, advancements in assisted reproductive technologies (ART), and growing awareness about reproductive health. Infertility is a condition that affects both men and women, with lifestyle factors, delayed pregnancies, stress, and medical conditions contributing to its rising prevalence. Healthcare innovations and increased access to fertility clinics are further fueling the demand for infertility treatments worldwide.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/infertility-treatment-market?rk

Key Highlights from the Report

➤ Rising infertility prevalence worldwide is driving demand for advanced treatment options.
➤ Assisted reproductive technology (ART) accounts for the largest revenue share in the market.
➤ North America leads the market, while Asia-Pacific is expected to grow at the fastest pace.
➤ Technological advancements such as AI in IVF and genetic screening are improving success rates.
➤ Fertility clinics remain the leading end-user segment due to increasing patient footfall.
➤ Government initiatives and insurance support in developed economies are boosting market adoption.

Market Segmentation

The infertility treatment market can be segmented by product type, procedure, patient type, and end-user. In terms of product type, the market includes equipment, media, and consumables. Equipment such as sperm analyzers, imaging systems, and ovum aspiration pumps play a critical role in enhancing treatment precision. Consumables, including culture media and reagents, also contribute significantly due to their recurring demand.

Based on procedures, the market is classified into assisted reproductive technology (ART), artificial insemination, fertility surgeries, and ovulation induction. ART, particularly IVF and intracytoplasmic sperm injection (ICSI), accounts for the largest share as these methods provide higher success rates compared to other procedures. Artificial insemination is also witnessing growing adoption due to its cost-effectiveness and accessibility.

When segmented by patient type, the market addresses both male and female infertility. Male infertility treatment is gaining attention with the availability of advanced diagnostic tools and therapies. On the other hand, female infertility continues to be the dominant segment due to higher diagnosis rates and treatment-seeking behavior.

End-user segmentation highlights fertility clinics, hospitals, and surgical centers. Fertility clinics dominate the market, as they provide specialized services, advanced equipment, and experienced healthcare professionals dedicated to infertility care.

Looking For A Detailed Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=infertility-treatment-market

Regional Insights

North America dominates the infertility treatment market, attributed to advanced healthcare infrastructure, rising awareness, and favorable insurance coverage for ART procedures. The United States plays a central role, with numerous fertility clinics, research institutions, and technological innovations in reproductive medicine.

Europe is the second-largest market, supported by favorable government policies, technological advancements, and increasing infertility prevalence. Countries like the UK, Germany, and France have well-established ART frameworks that drive growth.

The Asia-Pacific region is experiencing rapid growth, fueled by increasing infertility rates, economic development, and growing awareness of reproductive health. Countries such as India, China, and Japan are investing heavily in fertility healthcare infrastructure, making ART treatments more accessible to a broader population.

Latin America and the Middle East & Africa are gradually emerging markets, driven by improving healthcare infrastructure and rising acceptance of infertility treatments. However, limited affordability and cultural barriers in some regions may restrict growth.

Market Dynamics

Market Drivers
The primary driver of the infertility treatment market is the rising global prevalence of infertility, attributed to delayed pregnancies, lifestyle disorders, obesity, and stress. Technological advancements in ART, such as embryo freezing, genetic testing, and AI-enabled embryo selection, are improving success rates and patient satisfaction. Furthermore, government support and increasing medical tourism in countries like India and Thailand are creating new growth avenues.

Market Restraints
Despite significant growth potential, the market faces challenges such as the high cost of ART procedures, lack of awareness in underdeveloped regions, and limited insurance coverage in some countries. Ethical concerns and cultural stigmas around infertility treatments also act as barriers to adoption, particularly in conservative societies.

Market Opportunities
The market presents significant opportunities in emerging economies where infertility rates are climbing and healthcare infrastructure is rapidly expanding. Advances in precision medicine and personalized fertility treatment are likely to open new pathways for success. Additionally, the growing demand for fertility preservation among career-oriented individuals and cancer patients presents new revenue streams for the industry.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/infertility-treatment-market

Reasons to Buy the Report

✔ Comprehensive analysis of current and future market trends.
✔ Insights into regional market dynamics and growth opportunities.
✔ In-depth segmentation covering product, procedure, and end-user insights.
✔ Evaluation of the competitive landscape with profiles of key players.
✔ Access to forecasts and projections to support strategic decision-making.

Frequently Asked Questions (FAQs)

◆ How Big is the Global Infertility Treatment Market?
◆ Who are the Key Players in the Infertility Treatment Market?
◆ What is the Projected Growth Rate of the Infertility Treatment Market?
◆ What is the Market Forecast for Infertility Treatment by 2032?
◆ Which Region is Expected to Dominate the Infertility Treatment Industry?

Company Insights
Key players operating in the infertility treatment market include:

• Vitrolife AB
• Cook Medical LLC
• CooperSurgical Inc.
• Thermo Fisher Scientific Inc.
• Genea Limited
• IVFtech ApS
• The Baker Company Inc.
• FUJIFILM Irvine Scientific
• Merck KGaA
• Esco Micro Pte. Ltd.

Recent Developments:

In 2023, Merck KGaA expanded its fertility portfolio by launching new culture media solutions designed to improve embryo viability.

CooperSurgical announced a strategic partnership with fertility clinics across Asia-Pacific to strengthen its regional presence and enhance ART accessibility.

Conclusion

The infertility treatment market is on a growth trajectory, driven by rising infertility rates, technological innovations, and growing societal acceptance of ART procedures. While North America and Europe remain established leaders, the Asia-Pacific region is emerging as a major growth hub due to increasing demand and healthcare investments. Despite challenges such as high costs and cultural barriers, opportunities in personalized medicine, fertility preservation, and medical tourism are expected to fuel market expansion. Companies that continue to innovate and expand accessibility will play a pivotal role in shaping the future of infertility treatment worldwide.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infertility treatment market to grow from $2.9 Billion in 2024 to $6 Billion in 2033 at 8.1% CAGR, driven IVF adoption here

News-ID: 4165225 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comprehensive Analysis of Pancreatic Enzyme Replacement Therapy, Nutritional Management, Emerging Therapies, and Strategic Growth Opportunities
United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031. Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Therapeutics, Topical and Oral Formulations, Emerging Therapies, and Strategic Market Opportunities | GlaxoSmithKline Pharmaceuticals, Bauch Health Inc., Novartis AG
Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031. Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031: In-Depth Analysis of Immunoglobulin Therapy, Corticosteroids, Plasma Exchange, and Emerging Biologics | Top Companies are Grifols, Baxter, Kedrion S.p.A
United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031). Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth Analysis of Antivirals, Vaccines, Pain Management Therapies, and Emerging Therapeutic Innovations | Bausch Health Companies Inc., LNHC, Inc., GSK plc.
United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031. Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of

All 5 Releases


More Releases for ART

Art US Nation presents Immersive Art Exhibition "Art Attack" - at Art Basel Week …
The exclusive network of the AUN (art US Nation Association) creates an effective business platform for artists, art galleries, art collectors and influential art figures sharing the values and building a network of like-minded parties. Art US Nation Association successfully concluded its recent art exhibition "Art Attack" (Art Basel Week at Hilton), featuring a vibrant array of artworks from around the globe. Held at Hilton Miami Aventura, the exhibition captivated art
Art Collection Software Market to See Huge Growth by 2026 | Art Fundi, Art Binde …
The Latest Released Art Collection Software market study has evaluated the future growth potential of Art Collection Software market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential
11-30-2016 | Arts & Culture
Fusion Art
Fusion Art to Host "Art for Animals" Juried Art Exhibition for Charity
Palm Springs, CA, USA -- Fusion Art (http://www.fusionartps.com), a Palm Springs contemporary fine art gallery, will host an "Art for Animals" Juried Art Exhibition Fundraiser for Charity to support local Coachella Valley animal welfare organizations. The gallery has partnered with the Palm Springs Animal Shelter, SNIP, The Living Desert, Animal Samaritans, and the Humane Society of the Desert to host a charity art exhibition during the month of December 2016. All
Art Bengaluru’s International Art Auction
Includes artworks of celebrated International artists & unique lots including sculptures, coffee tables, chairs and other collectors’ items. Bangalore, India, Friday - August 24th, 2012 -- ‘Art Bengaluru 2012’ ( http://www.artbengaluru.in ), South India’s premier festival for contemporary art and culture, presents an iconic event as a part of its celebrations – an International Art Auction ( http://www.artbengaluru.in/auction.html ). The Auction, being presented by well-known auctioneer - Angira Arya, will take
Online Art Gallery Announces Call for Art - Theme “CityScapes” Art Contest
Jupiter, Florida - March 27, 2011 -- Light Space & Time Online Art Gallery is pleased to announce its April’s 2011 art competition. The theme for April is “CityScapes”. 2D Artists can submit their best Cityscape themed art for the Gallery’s May 2011 exhibition now. The submission process for artists ends April 28, 2011. All winners will be selected, announced and placed on the Light Space & Time website on May
VernissageTV covers Art Cologne 2010 art fair and shows video art
Basel, April 8, 2010 – As media partner of Art Cologne, VernissageTV art tv will cover Art Cologne 2010. The fair for modern and contemporary art will take place in Cologne, Germany from 21st to 25th April 2010. VernissageTV will provide its viewers with atmospheric shots from the fair, recordings of art talks, and in-depth interviews with artists, curators and dealers. The program will be shown on the websites of Art